During this paper, we conduct a comparative study of MCC950 towards the founded brokers PTX and SMS, as a possible different for long?expression suppression of NIH. Operating as a result of a wholly unique mechanism to PTX and SMS, we 1st exhibit in vitro that MCC950 is non?harmful to vascular cells